Last week I attended and spoke at a stem cell meeting at Rensselaer Polytechnic Institute (RPI). It was entitled, “Bioengineering and Stem Cell Research”. It was a great meeting with many interesting talks. Below I write about some of the talks and themes of the meeting. Still to come later this week I will do a second post entirely …
Rensselaer Polytechnic Institute stem cell meeting report Read More »
In two days the voting will end to pick the top 12 finalists for Stem Cell Person of the Year 2014 Award. You can vote here. From the finalists I will have the tough decision of picking the winner. Check out who’s in the top 12 now and who the top few vote getters are. Will someone surge …
Stem Cell Person of the Year Award: Only 2 Days Left To Vote Read More »
With one week left to vote to pick the top 12 finalists for the Stem Cell Person of the Year 2014 Award, we have more than 2,800 votes in so far. From the top 12 vote-getters, I will choose the winner. This is the third year of this award. I self-fund this award out of …
Stem Cell Person of the Year Award 2014 Voting: Who Will Be Finalists? Read More »
Nominations have closed and we have more than two dozen nominations for Stem Cell Person of the Year 2014. It’s an exciting, diverse group including some news faces as well as nominees from years past as well. Happy Stem Cell Day! You can now vote for your choice for the top finalists in the poll …
Stem Cell Person of the Year 2014 Award: Vote To Choose 12 Finalists Read More »
Stem cell biotech BioTime announced the news today that its subsidiary Cell Cure Neurosciences (Cell Cure) has filed an IND with the FDA for an embryonic stem (ES) cell-based therapy for Dry age-related macular degeneration (AMD). The product to be tested is OpRegen, which the company indicates is “the first IND for an ES cell-based …
BioTime’s Cell Cure Files IND with FDA for ES cell AMD therapy Read More »
When you want to both know the real history of the pluripotent stem cell-based biotech industry and perspectives on its future, there are only a handful of people to turn to and one of them is definitely Dr. Michael West, CEO of BioTime. I’m doing a several part series of blog posts on a lengthy …
BioTime CEO Mike West Interview Part 2: Geron & hESC Read More »
By Jeanne Loring. On Wednesday afternoon at the ISSCR meeting in Boston, Jamie Thomson gave a talk about the history of human pluripotent stem cells. There were probably only a dozen people in the audience of around 3,000 who were working on human ES cells around the same time that Jamie and Joseph Itskovitz-Eldor were …
Jeanne Loring’s Thought-Provoking Guest Post on Jamie Thomson’s ISSCR Talk Read More »